Navigation Links
Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
Date:11/29/2007

eclinical development. Bristol-Myers Squibb also has responsibility for clinical development, regulatory, manufacturing and sales/marketing activities for such compounds. At time of signing, Exelixis received a $17.5 million upfront payment and a commitment from Bristol-Myers Squibb to provide R&D funding of approximately $10 million per year for the initial two year period. Exelixis may also receive pre-specified development and regulatory milestones totaling approximately $140 million per product for up to two products from the collaboration, as well as sales milestones and royalties on sales of products commercialized under the collaboration.

In September 2007, Exelixis announced that the collaboration had been extended through January 12, 2009. Terms of the extension include additional research funding paid to Exelixis in the amount of $7.5 million. Bristol-Myers Squibb also has an option to further extend the collaboration by an additional year.

About the Liver X Receptor

LXR activation by endogenous ligands, oxysterols (oxidized cholesterol) or by synthetic agonists, initiates a cascade of cellular events that both increase "reverse cholesterol transport," thereby removing excess cholesterol from the body, and suppress inflammation. Elevated cholesterol concentrations have been implicated in the progression of heart disease and plaque formation in the artery wall. LXR activation therefore directly targets two well-known risk factors of heart disease and provides a novel approach for decreasing the deposition of fat and lipids in the artery wall and suppressing the inflammatory damage associated with atherosclerosis. In animal models of heart disease, small molecule synthetic LXR ligands have been shown to cause regression of pre-existing atherosclerotic lesions. Thus, LXR may be a first-in-class target for therapies that directly target the pathology of atherosclerosis and coronary artery disease via a dual mechanism of stimulating reverse
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Exelixis Commences Public Offering of Common Stock
2. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
3. Exelixis Announces October 10 Webcast of Presentation at the 2007 Bio InvestorForum Conference
4. Exelixis Announces November 6 Webcast of Presentation at the CIBC World Markets 18th Annual Healthcare Conference
5. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
6. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
7. DaVita Receives Civil Complaint
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
10. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
11. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... (PRWEB) December 26, 2014 “Many people ... with personal injury claim issues and phone calls with ... released an article featuring their free eBook on ... helpful eBook on pedestrian and bicycle auto accident claims ... is fully capable of professionally handling their case while ...
(Date:12/25/2014)... The microscopy market is estimated to grow ... million by 2019. Optical microscopy is the largest ... product segment is expected to show the fastest ... on nanotechnology, technological advancements, and increasing federal support ... Get Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... can receive effective, less expensive care from a clinic that ... team of dedicated health care professionals, a new study shows. ... need either hospitalization or a trip to the emergency room ... at the University of Texas in Houston versus usual care, ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... organ transplantation continues to entice the imagination of successive ... worldwide demand for human organs has prompted researchers to ... closer level.// ,The findings of a national ... a family discussion about organ donation, which is very ...
... the tongue may have taste sensors dedicated to detecting fat, ... foods. ,The study, which appears in the November ... and mice exhibit a spontaneous attraction for lipids. Such a ... for the detection of dietary lipids. The fatty acid transporter ...
... getting prepared to counter any bird flu cases in ... SARS earlier. //Philippines president Arroyo has appointed two important ... and also increase the awareness to people on possible ... her Agricultural Secretary Domingo Panganiban as the country's anti-avian ...
... - Swedish authorities panicked when a seagull suspected to have ... took extra precautions in handling the bird thinking that the ... ,Reports of sick poultry throughout Europe prompted the Swedish ... brought to them with a yellow fluid coming from its ...
... to be effective in treating patients with pancreatic cancer ... Gemcitabine and Capecitabine has been found to decrease the ... effective to pancreatic cancer is very important as Pancreatic ... cancers. It develops when malignant cells form in tissues ...
... Multiple sclerosis is a form of autoimmune disorder that occurs ... tissues. In multiple sclerosis, the antibodies are directed towards the ... most common symptom of the disease. It can be to ... in this regard is that MS appears to cause the ...
Cached Medicine News:Health News:Survey finds that discussion with family very crucial in organ donation decision 2Health News:Discovery of a built-in 'fat sensor' 2Health News:Effect Of Cooling And Exercise To Be Analyzed In Patients With Multiple Sclerosis 2
(Date:12/22/2014)... , Dec. 22, 2014 Apnea Sciences ... corporate offices in Aliso Viejo , ... due to the tremendous growth and worldwide expansion, a ... of patented SnoreRx, the anti snore cure have exceeded ... said, "We are now in 23 countries and ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... addition of the "Investment Analysis of the ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the US medical device sector identifies the key ... venture capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... and STOCKHOLM , Dec. 22, ... and partner Auxilium Pharmaceuticals, Inc. today announced that the ... the European Medicines Agency (EMA) has adopted a positive ... for the treatment of adult men with Peyronie,s disease ... least 30 degrees at the start of therapy. ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... of the technology world moves to Basking Ridge, NJ when ... Trade-Investment Promotion Agency (KOTRA), kicks off later this month. The ... together companies seeking the most innovative and creative technology in ... at 8:30AM EDT (US & Canada) at the Dolce Hotels ...
... DURHAM, N.C., Oct. 18 Argos Therapeutics ... president and chief executive officer, will present an overview of ... EDT on Oct. 21 at the inaugural Cancer Immunotherapy Conference ... Ph.D ., the company,s chief scientific officer and vice president ...
Cached Medicine Technology:Top U.S. and Korean Companies to Converge at 2010 Global Partnering Day 2Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference 2
... The In-Fast™ Ultra Sling is a minimally ... A concomitant repair surgery can be performed ... an abdominal incision.To place a sling, the ... two small titanium bone screws into the ...
... Delivers the advanced performance benefits ... strength, versatility, and durability ... that augments the effectiveness of ... floor reconstruction. Comprised of sterile, ...
... The FineTech-Brindley (also known as the ... which has been used by people with ... (or urinate) on demand. A secondary use ... bowel evacuation and promote penile erection.,The Bladder ...
Used for dilation of a tract to the kidney for removal of stones. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: